What are the major opportunities in the Luxturna market? What are the strategies for the Luxturna market?

For detailed insights on the major opportunities and strategies in the Luxturna market, Read More

How does the Luxturna market relate to the overall economy and other similar markets?

For detailed insights on Luxturna's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Luxturna industry?

For detailed insights on the mergers and acquisitions in the Luxturna industry, Read More

What are the key dynamics influencing the Luxturna market growth? SWOT analysis of the Luxturna market.

For detailed insights on the key dynamics influencing the Luxturna market growth and SWOT analysis of the Luxturna industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Luxturna Global Market Report 2025

Name: Luxturna Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Treatment Of RPE65-Mediated Inherited Retinal Disease, Management Of Vision Loss), By Patient Demographics (Pediatric Patients, Adult Patients, Patients With Early Diagnosis), By Distribution Channel (Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Ophthalmology Clinics, Specialty Pharmacies, Research Institutions)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Luxturna Market?

Luxturna is a gene therapy treatment used to treat patients with inherited retinal diseases caused by mutations in the RPE65 gene, which can lead to vision loss and blindness. It delivers a functional copy of the RPE65 gene directly into the retinal cells, allowing them to produce a protein necessary for vision.

The main types of indications for luxturna include treatment of RPE65-mediated inherited retinal disease and management of vision loss. Treatment of RPE65-mediated inherited retinal disease targets genetic mutations in the RPE65 gene that cause progressive vision loss and blindness, and Luxturna, a gene therapy, is delivered via subretinal injection to provide a functional RPE65 gene, improving vision in eligible patients. The patient demographics include pediatric patients, adult patients, and patients with early diagnosis, and distribution channels are categorized into direct sales, wholesalers and distributors, Retail Pharmacies, and online pharmacies for end users such as hospitals, ophthalmology clinics, specialty pharmacies, and research institutions.

Luxturna Market Size and growth rate 2025 to 2029: Graph

What Is The Luxturna Market Size 2025 And Growth Rate?

The luxturna market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of retinal diseases, rising aging population, increasing high patient demand, increased research in gene editing, and increasing investment in biotechnology.

What Is The Luxturna Market Growth Forecast?

The luxturna market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising genetic screening programs, rising demand for personalized medicine, increasing demand for new medication, rising interest in genetic cures, and rising approvals of innovative therapies. Major trends in the forecast period include advancements in gene therapy, integration with digital health solutions, technological innovations in gene delivery, gene editing technologies, and integration with AI-driven drug discovery.

Book your 30 minutes free consultation with our research experts

How Is The Luxturna Market Segmented?

The luxturna market covered in this report is segmented –

1) By Indication: Treatment Of RPE65-Mediated Inherited Retinal Disease, Management Of Vision Loss

2) By Patient Demographics: Pediatric Patients, Adult Patients, Patients With Early Diagnosis

3) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

4) By End User: Hospitals, Ophthalmology Clinics, Specialty Pharmacies, Research Institutions

What Is Driving The Luxturna Market? Growing Prevalence Of Genetic Eye Disorders And Advances In Gene Therapy

The rising prevalence of genetic eye disorders is expected to propel the growth of the luxturna market going forward. Genetic eye disorders refer to a range of inherited conditions caused by gene mutations that affect the eyes' structure or function, leading to visual impairments such as blindness or reduced vision. The rising prevalence of genetic eye disorders can be attributed to increased genetic mutations, aging populations, improved diagnostic technologies, and a greater awareness of hereditary conditions. Luxturna is a gene therapy used to treat genetic eye disorders, specifically inherited retinal diseases (IRDs) caused by mutations in the RPE65 gene, offering a potential cure by delivering a functional copy of the gene to restore vision. For instance, in December 2023, according to the United Nations Development Programme (UNDP), a US-based United Nations agency, the number of individuals diagnosed with vision impairments was 19,551 in 2022 compared to 17,478 in 2021. Moreover, over 19,000 new diagnoses have been reported in just the first seven months of 2023. Therefore, the rising prevalence of genetic eye disorders is driving the growth of the luxturna market.

What Is Driving The Luxturna Market? Rising Healthcare Expenditure To Accelerate Growth In Market

The rise in healthcare expenditure is expected to drive the luxturna market going forward. Healthcare expenditure is the total amount spent on medical services, treatments, and products by governments, businesses, or individuals. Healthcare expenditure is rising due to factors like aging populations, advancements in medical technology, increased prevalence of chronic diseases, and rising treatment costs. Rising healthcare expenditure supports Luxturna by enabling the funding and accessibility of advanced treatments like gene therapy for rare inherited retinal diseases, which are often expensive and require specialized care. For instance, in May 2023, according to the Office for National Statistics, a UK-based government organization, in 2022, healthcare expenditure in the UK amounted to approximately $367.9 billion (£283 billion), reflecting a nominal increase of 0.7% compared to the previous year. Therefore, a rise in healthcare expenditure will fuel the growth of the luxturna market.

Who Are The Major Players In The Global Luxturna Market?

Major companies operating in the luxturna market include F. Hoffmann-La Roche AG

What Are The Key Trends Of The Global Luxturna Market? Real-World Data And Efficacy Of Luxturna

A key trend in the luxturna market is conducting real-world studies for its gene therapies, such as adeno-associated virus vector-based gene therapy, to establish a reputation for transparency and commitment to patient outcomes. Adeno-associated virus (AAV) vector-based gene therapy uses a modified virus to deliver therapeutic genes to cells, offering treatment for genetic diseases like RPE65-related retinal dystrophy. For instance, in April 2023, Spark Therapeutics, a US-based biotechnology company specializing in gene therapy treatments, demonstrated real-world data for Luxturna (voretigene neparvovec), an AAV-based gene therapy for RPE65-related inherited retinal dystrophy (IRD), from 8 Belgian patients presented at the ARVO 2023 Annual Meeting. Among 15 treated eyes in the observational study, significant light sensitivity improvements were observed 6 months post-treatment for red, blue, and white light and enhancements in the visual field (object III4). At 2 years post-treatment, Luxturna showed a mean change of -0.03 BCVA and -13.67 decibels in the full-field light sensitivity threshold. Regarding safety, 35% of patients experienced at least one ocular adverse event, with chorioretinal atrophic changes being the most common, reported in 13 cases.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Luxturna Market

North America was the largest region in the luxturna market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the luxturna market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the luxturna market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Luxturna Market?

The luxturna market consists of sales of diagnostic kits, ocular imaging devices, cell therapy products, ophthalmic surgical instruments, retinal imaging systems, and patient monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Luxturna Industry?

The luxturna market research report is one of a series of new reports from The Business Research Company that provides luxturna market statistics, including luxturna industry global market size, regional shares, competitors with a luxturna market share, detailed luxturna market segments, market trends and opportunities, and any further data you may need to thrive in the luxturna industry. This luxturna market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Luxturna Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Indication: Treatment Of RPE65-Mediated Inherited Retinal Disease, Management Of Vision Loss 2) By Patient Demographics: Pediatric Patients, Adult Patients, Patients With Early Diagnosis 3) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies 4) By End User: Hospitals, Ophthalmology Clinics, Specialty Pharmacies, Research Institutions
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche AG
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Luxturna Market Characteristics

3. Luxturna Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Luxturna Market Trends And Strategies

5. Luxturna Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Luxturna Growth Analysis And Strategic Analysis Framework

6.1. Global Luxturna PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Luxturna Market Growth Rate Analysis

6.4. Global Luxturna Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Luxturna Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Luxturna Total Addressable Market (TAM)

7. Global Luxturna Pricing Analysis & Forecasts

8. Luxturna Market Segmentation

8.1. Global Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Treatment Of RPE65-Mediated Inherited Retinal Disease

Management Of Vision Loss

8.2. Global Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric Patients

Adult Patients

Patients With Early Diagnosis

8.3. Global Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Direct Sales

Wholesalers And Distributors

Retail Pharmacies

Online Pharmacies

8.4. Global Luxturna Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Ophthalmology Clinics

Specialty Pharmacies

Research Institutions

9. Global Luxturna Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Luxturna Market Regional And Country Analysis

10.1. Global Luxturna Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Luxturna Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Luxturna Market

11.1. Asia-Pacific Luxturna Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Luxturna Market

12.1. China Luxturna Market Overview

12.2. China Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Luxturna Market

13.1. India Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Luxturna Market

14.1. Japan Luxturna Market Overview

14.2. Japan Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Luxturna Market

15.1. Australia Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Luxturna Market

16.1. South Korea Luxturna Market Overview

16.2. South Korea Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Luxturna Market

17.1. Western Europe Luxturna Market Overview

17.2. Western Europe Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Luxturna Market

18.1. UK Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Luxturna Market

19.1. Germany Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Luxturna Market

20.1. France Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Luxturna Market

21.1. Eastern Europe Luxturna Market Overview

21.2. Eastern Europe Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Luxturna Market

22.1. North America Luxturna Market Overview

22.2. North America Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Luxturna Market

23.1. USA Luxturna Market Overview

23.2. USA Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Luxturna Market

24.1. Canada Luxturna Market Overview

24.2. Canada Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Luxturna Market

25.1. South America Luxturna Market Overview

25.2. South America Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Luxturna Market

26.1. Middle East Luxturna Market Overview

26.2. Middle East Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Luxturna Market

27.1. Africa Luxturna Market Overview

27.2. Africa Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Luxturna Market Competitive Landscape And Company Profiles

28.1. Luxturna Market Competitive Landscape

28.2. Luxturna Market Company Profiles

28.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

29. Global Luxturna Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Luxturna Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Luxturna Market

32. Recent Developments In The Luxturna Market

33. Luxturna Market High Potential Countries, Segments and Strategies

33.1 Luxturna Market In 2029 - Countries Offering Most New Opportunities

33.2 Luxturna Market In 2029 - Segments Offering Most New Opportunities

33.3 Luxturna Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Luxturna Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Luxturna Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Luxturna Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: F. Hoffmann-La Roche AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Luxturna Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Luxturna Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Luxturna Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Luxturna Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Luxturna Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Luxturna Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: F. Hoffmann-La Roche AG Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Oncology Drugs Global Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Canc...

Ophthalmology Drugs Global Market Report 2022 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)), By Distribution Channel (Hospital Pharmacies, R...

Frequently Asked Questions

What is the definition of the Luxturna market?

How will the Luxturna market drivers and restraints affect the market dynamics? What forces will shape the Luxturna industry going forward?

The Luxturna market major growth driver - Growing Prevalence Of Genetic Eye Disorders And Advances In Gene Therapy. For further insights on the Luxturna market, request a sample here

What is the forecast market size or the forecast market value of the Luxturna market?

The Luxturna market size has grown strongly in recent years. The luxturna market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of retinal diseases, rising aging population, increasing high patient demand, increased research in gene editing, and increasing investment in biotechnology. The luxturna market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to rising genetic screening programs, rising demand for personalized medicine, increasing demand for new medication, rising interest in genetic cures, and rising approvals of innovative therapies. Major trends in the forecast period include advancements in gene therapy, integration with digital health solutions, technological innovations in gene delivery, gene editing technologies, and integration with AI-driven drug discovery. For further insights on the Luxturna market, request a sample here

How is the Luxturna market segmented?

The luxturna market covered in this report is segmented –
1) By Indication: Treatment Of RPE65-Mediated Inherited Retinal Disease, Management Of Vision Loss
2) By Patient Demographics: Pediatric Patients, Adult Patients, Patients With Early Diagnosis
3) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
4) By End User: Hospitals, Ophthalmology Clinics, Specialty Pharmacies, Research Institutions For further insights on the Luxturna market, request a sample here

Which region has the largest share of the Luxturna market? What are the other regions covered in the report?

Who are the major players in the Luxturna market?

Major companies operating in the luxturna market include F. Hoffmann-La Roche AG . For further insights on the Luxturna market, request a sample here.

What are the key trends in the Luxturna market?

Major trends in the Luxturna market include Real-World Data And Efficacy Of Luxturna. For further insights on the Luxturna market, request a sample here.